ethinylestradiol 20microgram / drospirenone 3mg tablets
imported - drospirenone; ethinylestradiol - oral tablet - 3mg ; 20microgram
drospirenone tablet
popular pharmaceuticals ltd. - drospirenone + ethinylestradiol - tablet - 3 mg + .03 mg
loryna- drospirenone and ethinyl estradiol
sandoz inc - drospirenone (unii: n295j34a25) (drospirenone - unii:n295j34a25), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - drospirenone 3 mg - lorynatm (drospirenone and ethinyl estradiol tablets) are indicated for use by women to prevent pregnancy. lorynatm tablets are indicated for the treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. drospirenone and ethinyl estradiol tablets should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control. do not prescribe drospirenone and ethinyl estradiol to women who are known to have the following: - renal impairment - adrenal insufficiency - a high risk of arterial or venous thrombotic diseases. examples include women who are known to: smoke, if over age 35 [see boxed warning and warnings and precautions (5.1) ] have deep vein thrombosis or pulmonary embolism, now or in the past [see warnings and precautions (5.1) ] have cerebrovascular disease [see warnings and precautions (5.1) ] have coronary artery disease [see w
syeda- drospirenone and ethinyl estradiol
sandoz inc - drospirenone (unii: n295j34a25) (drospirenone - unii:n295j34a25), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - drospirenone 3 mg - syedatm (drospirenone and ethinyl estradiol tablets) are indicated for use by women to prevent pregnancy. do not prescribe syedatm to women who are known to have the following: - renal impairment - adrenal insufficiency - a high risk of arterial or venous thrombotic diseases. examples include women who are known to: smoke, if over age 35 [see boxed warning and warnings and precautions(5.1)] have deep vein thorombosis or pulmonary embolism, now or in the past [see warnings and precautions (5.1)] have cerebrovascular disease [see warnings and precautions (5.1)] have coronary artery disease [see warnings and precautions (5.1)] have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrilation) [see warnings and precautions (5.1)] have inherited or acquired hypercoagulopathies [see warnings and precautions (5.1)] have uncontrolled hypertension [see warnings
carmenelle 0.02/3 milligram film coated tablet
clonmel healthcare ltd - drospirenone, ethinylestradiol - film coated tablet - 0.02/3 milligram - progestogens and estrogens, fixed combinations
liza 0.03mg3mg film-coated tablet
eurodrug laboratories (m) sdn. bhd. - drospirenone; ethinylestradiol -
liz 0.02mg3mg film-coated tablet
eurodrug laboratories (m) sdn. bhd. - drospirenone; ethinylestradiol -
lizelle 0.02mg3mg film-coated tablet
eurodrug laboratories (m) sdn. bhd. - drospirenone; ethinylestradiol -
freedo & placebo 0.03 / 3 milligram film coated tablet
rowex ltd - drospirenone, ethinylestradiol - film coated tablet - 0.03 / 3 milligram - progestogens and estrogens, fixed combinations
freedonel & placebo 0.02 / 3 milligram film coated tablet
rowex ltd - drospirenone, ethinylestradiol - film coated tablet - 0.02 / 3 milligram - progestogens and estrogens, fixed combinations